Biggest News Aggregation in the World
๐Ÿ“ฐ Medication Guide News

Page 3 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa

Randomized Phase 2 study met the primary endpoint in patents with hidradenitis suppurativa , reinforcing efficacy and safety profile of ruxolitinib cream Results presented as a late-breaking...
United States San Diego Hidradenitis Suppurativa Incyte Corporation Exchange Commission Rare Diseases Information Center

Samsung Bioepis Presents Two Abstracts for Its Immunology Portfolio at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Interchangeability study for HADLIMA (adalimumab-bwwd) was conducted in accordance with the FDA’s Guidance for Industry; primary pharmacokinetics (PK) endpoints as well as efficacy, safety and immunogenicity profiles were comparable between switching group and continuous reference product Humira group 52-week results from SB17 Phase 3 study demonstrated long-term efficacy, safety, and immunogenicity of SB17 compared to reference ustekinumab, including switching from ustekinumab to SB17 IN...
United States San Diego Skaidra Valiukevi Maria Agnieszka Zegadlo Mylik Lidia Rajzer Ilsun Hong
Source: yahoo.com

U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of the supplemental Biologics...
United States Hematol Hemoter Mariana Cota Stirner Us Inc European Union Data From The Observational National Lymphocare Study

New England Journal of Medicine Publishes Phase III Data Showing Xolair Significantly Reduced Allergic Reactions Across Multiple Foods in People With Food Allergies

โ€“ Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year...
United States South San Francisco Stanford School Levi Garraway R Sharon Chinthrajah Robert Wood

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

AbbVie Unveils New Data from Robust Gastroenterology Portfolio at the 19th Congress of European Crohn's and Colitis Organisation (ECCO)

โ€“ A total of 17 accepted abstracts, including nine oral presentations and eight posters, reinforceย AbbVies commitment to produce a portfolio of products that aim to improve the lives of patients...
United States Remo Panaccione Ann Gastroenterol Gastroenterol Hepatol International Medical Affairs Drug Administration

FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergi

โ€“ Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placebo โ€“โ€“ More than 40% o...
United States South San Francisco Stanford School Levi Garraway Lindsey Mathias Loren Kalm

Heart to Heart With a Leading Cardiologist: What You Need to Know About Coronary Artery Disease

(BPT) - Did you know that the heart beats about 70 times per minute?1 Despite this muscle only being about the size of your fist, it is responsible for pumping oxygen-rich blood throughout your entire body 24/7 using arteries or blood vessels.1When the...
North Carolina United States Manesh Patel Johnson Manesh Patel Janssen Pharmaceuticals Inc American College Of Cardiology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science